Sinphar Tian-Li Pharmaceutical Co., Ltd.(Hangzhou) is a subsidiary of Taiwan listed company Sinphar Pharmaceutical Group and is the largest overseas investment of Xinghui Group. In 2001, Sinphar Tianli Pharmaceuticals was established in Yuhang District, Hangzhou City, Zhejiang Province under the guidelines of Xinghui's Board of Directors, "Layout Globally, Stride Globally, Develop Global Strategy and Vision".
Sinphar-Walnut Peptide Powder Protygold®
Xinghui Tianli obtained two certificates of ISO22000 and HACCP
From June 20 to 22, 2018, Xinghui Tianli team participated in the 18th World Pharmaceutical Raw Materials China Exhibition (CPHI) held in Shanghai.
